Please assess the completion status of the following clinical trial:

Trial Title: Improve Glaucoma Medication Adherence

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of open angle glaucoma \[primary open angle glaucoma, pigment dispersion glaucoma, pseudoexfoliation glaucoma, combined mechanism glaucoma, low tension glaucoma\] recorded in the medical record~* Prescribed glaucoma eye drops,~* Visual field performed within the last 9 months.~  * As visual field testing is standard care glaucoma and the investigators wish to establish baseline glaucoma severity, the investigators will require that subjects have a visual field test documented in the chart within 9 months of enrollment.~Exclusion Criteria:~Exclusion criteria for patients At Screener:~* How confident are you that you always remember to use your glaucoma medications?~  * not at all confident~ * somewhat confident~ * very confident)~* And In the past 4 weeks, did you ever forget to take your medicine?~  * Veterans who respond both very confident and no, respectively, will be excluded~Inclusion criteria for companions at screener:~* Willing to participate in assisting the patient with glaucoma drops and~* Willing to accompany the patient to the intervention visit for participants in the intervention arm or eye health education visit for participants in the control arm.~Exclusion criteria for companions: Unable or unwilling to attend baseline visit and intervention or control arm educational session with patient participant.~Exclusion criteria for patients or companions:~* Lacks proficiency in English,~* Lacks either a cell phone or landline phone.~Exclusion criteria for patients post randomization:~* Decision by patient and provider to cease glaucoma medication use~* Change in functional status such that the drops are no longer administered by the patient or the companion (such as nursing home care)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intervention (Type: EXPERIMENTAL): Participants will be randomized to receive either a general eye health educational session (control arm) or an educational intervention developed to improve glaucoma medication adherence (intervention arm). All participants will be provided with a smart bottle to house one of their glaucoma medications. The smart bottle records the date and time that the bottle is opened.
- Control (Type: ACTIVE_COMPARATOR): Participants will be randomized to receive either a general eye health educational session (control arm) or an educational intervention developed to improve glaucoma medication adherence (intervention arm). All participants will be provided with a smart bottle to house one of their glaucoma medications. The smart bottle records the date and time that the bottle is opened.

Based on this trial design, predict the completion outcome and termination type (if applicable).